Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Donaldson's Isolere Bio launches IsoTag reagent for optimal AAV purification
The IsoTag AAV reagent can purify adeno associated viruses for research purposes, achieving up to an 85% in yield
Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA
The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors
groninger showcases filling and closing solutions for OTC pharma at Pack Expo
Discover the flexcare 101 and flexfill machines designed for enhanced efficiency and flexibility in pharmaceutical production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Glenmark receives Czech GMP certificate for Indian facility
Glenmark Pharmaceuticals' Baddi manufacturing unit in the India has fulfilled GMP recommendation in line with the WHO
Pharmaceutical
Horizon signs license agreement with Glenmark for CHO cell line
gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line has been licenced to be incorporated into the biomanufacturing process
Manufacturing
Glenmark chooses Novartis for respiratory products
The Seebri, Onbrize and Ultibro products are indicated for COPD symptoms and will be manufactured by Novartis for Glenmark's Brazilian subsidiary
Logistics
Glenmark Pharmaceuticals awards UK supply chain to Yusen Logistics
Yusen Logistics, the award-winning pharmaceutical global logistics specialist, has been awarded a major contract by India-based pharmaceutical manufacturer Glenmark Pharmaceuticals
Regulatory
Indian pricing authority to address overcharging by pharma companies
NPPA has decided to chase drug majors for defaulting on penalties that have been imposed for overcharging consumers for medicines
Pharmaceutical
Indian pharma firms develop niche portfolios
They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical
Indian generic manufacturers aim to enter the Japanese market
The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Subscribe now